PMID- 31195769
OWN - NLM
STAT- MEDLINE
DCOM- 20191101
LR  - 20221207
IS  - 2208-7958 (Electronic)
VI  - 47
IP  - 10
DP  - 2018 Oct
TI  - Medication management of type 2 diabetes in residential aged care.
PG  - 675-681
LID - 10.31128/AJGP-05-18-4582 [doi]
AB  - BACKGROUND: Medication management of type 2 diabetes mellitus (T2DM) in 
      residential aged care facilities (RACFs) requires consideration of the residents' 
      goals of care and susceptibility to adverse drug events (ADEs). OBJECTIVE: The 
      aim of this article is to review best practice medication management for 
      residents diagnosed with T2DM. DISCUSSION: Management of T2DM in RACFs is often 
      focused on maintaining residents' quality of life rather than intensive glycaemic 
      management to reduce chronic complications, because the risks of intensive 
      glycaemic management typically outweigh the potential benefits. Australian RACF 
      guidelines recommend individualised glycated haemoglobin targets of 7-8.5% (53-69 
      mmol/mol). Strategies to reduce the risk of preventable ADEs may include 
      education for residents, carers and staff; assessment of hypoglycaemic risk and 
      renal function; medication review and regimen simplification; de-intensification 
      of glucose-lowering medications; and appropriate end-of-life medication 
      management. Use of a resident-centred multidisciplinary approach and resources 
      tailored to the RACF setting will support residents to achieve best possible 
      health outcomes and quality of life.
FAU - Stasinopoulos, Jacquelina
AU  - Stasinopoulos J
AD  - BHumNut, BPharm (Hons), GradCertPharmPrac, Centre for Medicine Use and Safety, 
      Faculty of Pharmacy and Pharmaceutical Sciences, Monash University, Parkville, 
      Vic. jacquelina. stasinopoulos@monash.edu
FAU - Bell, J Simon
AU  - Bell JS
AD  - BPharm (Hons), PhD, Centre for Medicine Use and Safety, Faculty of Pharmacy and 
      Pharmaceutical Sciences, Monash University, Parkville, Vic; NHMRC Cognitive 
      Decline Partnership Centre, Hornsby Ku-ring-gai Hospital, Hornsby, NSW; NHMRC 
      Centre for Research Excellence in Frailty and Healthy Ageing, Adelaide, SA; 
      School of Public Health and Preventive Medicine, Faculty of Medicine, Nursing and 
      Health Sciences, Monash University, Melbourne, Vic; Sansom Institute, School of 
      Pharmacy and Medical Sciences, University of South Australia, Adelaide, SA
FAU - Manski-Nankervis, Jo-Anne
AU  - Manski-Nankervis JA
AD  - BSc (Hons), MBBS (Hons), PhD, FRACGP, Department of General Practice, Melbourne 
      Medical School, Faculty of Medicine, Dentistry & Health Sciences, The University 
      of Melbourne, Carlton, Vic
FAU - Hogan, Michelle
AU  - Hogan M
AD  - BNurs, RN, Credentialled Diabetes Educator, Helping Hand Aged Care, North 
      Adelaide, SA
FAU - Jenkin, Peter
AU  - Jenkin P
AD  - RN, NP, MPHC (PallCare), MN(NursPrac), Resthaven Incorporated, Adelaide, SA
FAU - Sluggett, Janet K
AU  - Sluggett JK
AD  - BPharm (Hons), GDipClinEpid, PhD, Centre for Medicine Use and Safety, Faculty of 
      Pharmacy and Pharmaceutical Sciences, Monash University, Parkville, Vic; NHMRC 
      Cognitive Decline Partnership Centre, Hornsby Ku-ring-gai Hospital, Hornsby, NSW
LA  - eng
PT  - Journal Article
PT  - Research Support, Non-U.S. Gov't
PL  - Australia
TA  - Aust J Gen Pract
JT  - Australian journal of general practice
JID - 101718099
RN  - 0 (Blood Glucose)
RN  - 0 (Glycated Hemoglobin A)
RN  - 0 (Hypoglycemic Agents)
RN  - 0 (hemoglobin A1c protein, human)
SB  - IM
MH  - Australia
MH  - Blood Glucose/analysis
MH  - Delivery of Health Care/methods
MH  - Diabetes Mellitus, Type 2/*drug therapy/physiopathology
MH  - Drug Utilization Review/methods
MH  - Glycated Hemoglobin/analysis
MH  - Humans
MH  - Hypoglycemic Agents/administration & dosage/therapeutic use
MH  - Medication Systems/*standards/trends
MH  - Residential Facilities/organization & administration/trends
EDAT- 2019/06/15 06:00
MHDA- 2019/11/02 06:00
CRDT- 2019/06/15 06:00
PHST- 2019/06/15 06:00 [entrez]
PHST- 2019/06/15 06:00 [pubmed]
PHST- 2019/11/02 06:00 [medline]
AID - 10.31128/AJGP-05-18-4582 [doi]
PST - ppublish
SO  - Aust J Gen Pract. 2018 Oct;47(10):675-681. doi: 10.31128/AJGP-05-18-4582.